Actavis to Buy Durata for $675 Million to Gain Skin Drug (1)
Alert: HALISTER Source: BN (Bloomberg News)
Tickers ACT US (Actavis plc) DRTX US (Durata Therapeutics Inc) PEF1057 US (Aisling Capital III LP)
People Brenton Saunders (Actavis plc)
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283